Michael Barbella, Managing Editor12.12.22
Endoluxe has joined NVIDIA Inception, a program designed to support startups revolutionizing industries with artificial intelligence.
“We are honored to be accepted into the NVIDIA Inception program,” Endoluxe Cofounder and Chief Innovation Officer Dr. Neal Patel said. “NVIDIA is a world leader in artificial intelligence, and it will be incredibly beneficial to work with their medical imaging and healthcare AI offerings and services to build out Endoluxe’s surgical intelligence platform. We are especially excited to join the group of surgical visualization companies using the NVIDIA Clara Holoscan platform. It is the perfect choice to power artificial intelligence in our unique surgical visualization system.”
NVIDIA Inception will allow Endoluxe to access NVIDIA’s array of medical vision technology, helping drive the company’s clinical decision support using edge computing. The program will also offer Endoluxe the opportunity to collaborate with experts and other AI-driven organizations using NVIDIA technology.
Endoluxe’s first product—used in minimally invasive surgery—is a wireless endoscopic camera system platform with an onboard light source. The Endoluxe Vision system leverages powerful hardware at the edge to provide AI-powered clinical insights that can support clinicians and lead to better patient outcomes.
“When I had the opportunity to see Endoluxe’s technology, I immediately recognized the benefits that NVIDIA Inception would offer. Endoluxe is building an innovative visualization platform with clinical decision support that will greatly benefit from the NVIDIA portfolio,” Activ Surgical Chief Technology Officer Tom Calef said. Activ Surgical, which has had great success in the NVIDIA Inception program, is focused on enabling a future of augmented reality and artificial intelligence-driven surgery that is safe, smart and accessible to all.
NVIDIA Inception helps startups during critical stages of product development, prototyping and deployment. Every NVIDIA Inception member gets a custom set of ongoing benefits, such as NVIDIA Deep Learning Institute credits, marketing support, and technology assistance, which provides startups with the fundamental tools to help them grow.
Endoluxe is an endoscopic video imaging organization based in the United States, with worldwide distribution of its Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor-agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices—while taking advantage of future technological advancements using our portable, integrated and feature-laden platform at one-quarter the cost of legacy products.
“We are honored to be accepted into the NVIDIA Inception program,” Endoluxe Cofounder and Chief Innovation Officer Dr. Neal Patel said. “NVIDIA is a world leader in artificial intelligence, and it will be incredibly beneficial to work with their medical imaging and healthcare AI offerings and services to build out Endoluxe’s surgical intelligence platform. We are especially excited to join the group of surgical visualization companies using the NVIDIA Clara Holoscan platform. It is the perfect choice to power artificial intelligence in our unique surgical visualization system.”
NVIDIA Inception will allow Endoluxe to access NVIDIA’s array of medical vision technology, helping drive the company’s clinical decision support using edge computing. The program will also offer Endoluxe the opportunity to collaborate with experts and other AI-driven organizations using NVIDIA technology.
Endoluxe’s first product—used in minimally invasive surgery—is a wireless endoscopic camera system platform with an onboard light source. The Endoluxe Vision system leverages powerful hardware at the edge to provide AI-powered clinical insights that can support clinicians and lead to better patient outcomes.
“When I had the opportunity to see Endoluxe’s technology, I immediately recognized the benefits that NVIDIA Inception would offer. Endoluxe is building an innovative visualization platform with clinical decision support that will greatly benefit from the NVIDIA portfolio,” Activ Surgical Chief Technology Officer Tom Calef said. Activ Surgical, which has had great success in the NVIDIA Inception program, is focused on enabling a future of augmented reality and artificial intelligence-driven surgery that is safe, smart and accessible to all.
NVIDIA Inception helps startups during critical stages of product development, prototyping and deployment. Every NVIDIA Inception member gets a custom set of ongoing benefits, such as NVIDIA Deep Learning Institute credits, marketing support, and technology assistance, which provides startups with the fundamental tools to help them grow.
Endoluxe is an endoscopic video imaging organization based in the United States, with worldwide distribution of its Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor-agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices—while taking advantage of future technological advancements using our portable, integrated and feature-laden platform at one-quarter the cost of legacy products.